Minerva Surgical Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Minerva Surgical are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Minerva Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Minerva Surgical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 48.4 M | |
| Free Cash Flow | -35.6 M |
Minerva |
Minerva Surgical Relative Risk vs. Return Landscape
If you would invest (100.00) in Minerva Surgical on December 1, 2024 and sell it today you would earn a total of 100.00 from holding Minerva Surgical or generate -100.0% return on investment over 90 days. Minerva Surgical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Minerva, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Minerva Surgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Minerva Surgical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Minerva Surgical, and traders can use it to determine the average amount a Minerva Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| UTRS |
Based on monthly moving average Minerva Surgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Minerva Surgical by adding Minerva Surgical to a well-diversified portfolio.
Minerva Surgical Fundamentals Growth
Minerva Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Minerva Surgical, and Minerva Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Minerva Pink Sheet performance.
| Return On Equity | -1.6 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 42.81 M | ||||
| Shares Outstanding | 8.88 M | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 0.25 X | ||||
| Revenue | 50.29 M | ||||
| EBITDA | (30.88 M) | ||||
| Cash And Equivalents | 22.39 M | ||||
| Cash Per Share | 0.78 X | ||||
| Total Debt | 39.69 M | ||||
| Debt To Equity | 1.30 % | ||||
| Book Value Per Share | 2.28 X | ||||
| Cash Flow From Operations | (35.57 M) | ||||
| Earnings Per Share | (7.61) X | ||||
| Total Asset | 68.9 M | ||||
| Retained Earnings | (283.67 M) | ||||
Things to note about Minerva Surgical performance evaluation
Checking the ongoing alerts about Minerva Surgical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Minerva Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Minerva Surgical is not yet fully synchronised with the market data | |
| Minerva Surgical has some characteristics of a very speculative penny stock | |
| Minerva Surgical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 50.29 M. Net Loss for the year was (34.11 M) with profit before overhead, payroll, taxes, and interest of 27.24 M. | |
| Minerva Surgical currently holds about 22.39 M in cash with (35.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
| Over 90.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Minerva Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Minerva Surgical's stock is overvalued or undervalued compared to its peers.
- Examining Minerva Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Minerva Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Minerva Surgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Minerva Surgical's pink sheet. These opinions can provide insight into Minerva Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Minerva Pink Sheet
If you are still planning to invest in Minerva Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Minerva Surgical's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |